Sage Journals: Discover world-class research

Abstract

Objective:

The aim of this systematic review was to assess the effectiveness of progressive muscle relaxation on psychological distress and anxiety symptoms and on response/remission for people with schizophrenia.

Methods:

Randomized controlled trials were considered if they investigated progressive muscle relaxation in patients with schizophrenia. EMBASE, PsycINFO, PubMed, ISI Web of Science, CINAHL, PEDro and Cochrane Library were searched. The selection of studies, data extraction and quality assessment were performed independently by two reviewers.

Results:

Three randomized controlled trials involving 146 patients met the inclusion criteria. Progressive muscle relaxation can acutely reduce state anxiety and psychological distress and improve subjective well-being. No studies investigated the evidence for progressive muscle relaxation as an add-on treatment for general psychopathology and for positive or negative symptoms. Also, no studies assessed the value of progressive muscle relaxation in longer-term treatment and for relapse prevention. There were no data to draw any conclusions about progressive muscle relaxation in comparison with other treatment modalities. None of the studies encountered adverse events. Dose-response relationships could not be determined.

Conclusion:

Progressive muscle relaxation might be a useful add-on treatment to reduce state anxiety and psychological distress and improve subjective well-being in persons with schizophrenia.

Keywords

Progressive muscle relaxation physical therapy rehabilitation schizophrenia state anxiety well-being

Get full access to this article

View all access options for this article.

References

van Os

Kapur

. Schizophrenia. Lancet 2009; 374: 635–645.

American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington DC: American Psychiatric Press Inc, 1994.

McGrath

Saha

Chant

Welham

. Schizophrenia: a concise overview of incidence, prevalence, and mortality. Epidemiol Rev 2008; 30: 67–76.

van Winkel

Esquivel

Kenis

. Genome-wide findings in schizophrenia and the role of gene-environment interplay. CNS Neurosci Ther 2010; 16: 185–192.

van Winkel

Stefanis

Myin-Germeys

. Psychosocial stress and psychosis. A review of the neurobiological mechanisms and the evidence for gene-stress interaction. Schizophr Bull 2008; 34: 1095–1105.

Achim

Maziade

Raymond

Olivier

Mérette

Roy

. How prevalent are anxiety disorders in schizophrenia? A meta-analysis and critical review on a significant association. Schizophr Bull 2011; 37(4): 811–821.

Vázquez Pérez

Godoy-Izquierdo

Godoy

. Clinical outcomes of a coping with stress training program among patients suffering from schizophrenia and schizoaffective disorder: a pilot study. Anxiety Stress Coping 2012. DOI: 10.1080/10615806.2012.654778.

Kern

Glynn

Horan

Marder

. Psychosocial treatments to promote functional recovery in schizophrenia. Schizophr Bull 2009; 35: 347–361.

Probst

Knapen

Poot

Vancampfort

. Psychomotor therapy and psychiatry: What is in a name? Open Compl Med J 2010; 2: 105–113.

10.

Vancampfort

Probst

Knapen

Demunter

Peuskens

De Hert

. Body-directed techniques on psychomotor therapy for people with schizophrenia: a review of the literature. Tijdschr Psychiatry 2011; 53(8): 531–541.

11.

Vancampfort

Vansteelandt

Scheewe

. Yoga in schizophrenia: a systematic review of randomized controlled trials. Acta Psychiatr Scand 2012; 126(1): 12–20.

12.

Vancampfort

Probst

Helvik Skjaerven

. Systematic review of the benefits of physical therapy within a multidisciplinary care approach for people with schizophrenia. Phys Ther 2012; 92(1): 11–23.

13.

Jacobson

. Progressive relaxation. Chicago: Chicago University Press, 1939.

14.

Bernstein

Borkovec

. Progressive relaxation training. Champaign, IL: Research Press, 1973.

15.

Bernstein

Carlson

. Progressive relaxation: Abbreviated methods. In: Lehrer

Woolfolk

(eds) Principles and practice of stress management. New York: Guilford Press, 1993. pp.53–87.

16.

Moher

Liberati

Tetzlaff

Altman

. PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses, the PRISMA statement. BMJ 2009; 339: 2535.

17.

Jadad

Moore

Carroll

. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996; 17: 1–12.

18.

Chen

Chu

. Efficacy of progressive muscle relaxation training in reducing anxiety in patients with acute schizophrenia. J Clin Nurs 2009; 18: 2187–2196.

19.

Vancampfort

De Hert

Knapen

. Effects of progressive muscle relaxation on state anxiety and subjective well-being in people with schizophrenia: a randomized controlled trial. Clin Rehab 2011; 25(6): 567–575.

20.

Georgiev

Probst

De Hert

Genova

Tonkova

Vancampfort

. Progressive muscle relaxation in schizophrenia: a replication study on state anxiety and subjective well-being effects in chronic Bulgarian patients. Psychiatr Danub 2012; in press.

21.

Spielberger

. Manual for the state-trait anxiety inventory. Consulting Psychologists Press, 1983.

22.

Oei

Evans

Crook

. Utility and validity of the STAI with anxiety disorder patients. Br J Clin Psychology 1990; 29(4): 429–432.

23.

Beck

Brown

Epstein

Steer

. An inventory for measuring clinical anxiety–psychometric properties. J Consult Clin Psychol 1988; 56: 893–897.

24.

Fydrich

Dowdall

Chambless

. Reliability and validity of the Beck Anxiety Inventory. J Anxiety Disord 1992; 6: 55–61.

25.

McAuley

Courneya

. The subjective exercise experiences scale: Development and preliminary validation. J Sport Exerc Psychol 1994; 16: 163–177.

26.

Snyder

. Progressive relaxation. In: Snyder

(ed.) Independent nursing interventions. 2nd ed. Albany, NY: Delmar Publishers, 1992. pp.47–52.

27.

Green

Drake

Brunette

Noordsy

. Schizophrenia and co-occurring substance use disorder. Am J Psychiatry 2007; 164: 402–408.

28.

Gregg

Barrowclough

Haddock

. Reasons for increased substance use in psychosis. Clin Psychol Rev 2007; 27: 494–510.

29.

Barr

Procyshyn

Hui

Johnson

Honer

. Self-reported motivation to smoke in schizophrenia is related to antipsychotic drug treatment. Schizophr Res 2008; 100: 252–260.

30.

Winterer

. Why do patients with schizophrenia smoke? Curr Opin Psychiatry 2010; 23: 112–119.

31.

Atsberger

. Relaxation therapy: it’s potential as an intervention for acute postoperative pain. J Post Anesthesia Nurs 1995; 10: 2–8.

32.

Pawlow

Jones

. The impact of abbreviated progressive muscle relaxation on salivary cortisol and salivary immunoglobulin A (sIgA). Appl Psychophysiol Biofeedback 2005; 30: 375–387.

33.

Conrad

Roth

. Muscle relaxation therapy for anxiety disorders: it works but how? J Anxiety Disord 2007; 21: 243–264.

34.

Moher

Schulz

Altman

. The CONSORT statement: revised recommendations for improving the quality of reports of parallel group randomized trials. BMC Med Res Methodol 2001; 1: 2.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.01 MB

Progressive muscle relaxation in persons with schizophrenia: a systematic review of randomized controlled trials

Abstract

Objective:

Methods:

Results:

Conclusion:

Keywords

Get full access to this article

References

Supplementary Material